Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01951690
Title Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

lung non-small cell carcinoma

Therapies

Defactinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.